CN101243103A - 高血压症治疗剂 - Google Patents
高血压症治疗剂 Download PDFInfo
- Publication number
- CN101243103A CN101243103A CNA2006800302630A CN200680030263A CN101243103A CN 101243103 A CN101243103 A CN 101243103A CN A2006800302630 A CNA2006800302630 A CN A2006800302630A CN 200680030263 A CN200680030263 A CN 200680030263A CN 101243103 A CN101243103 A CN 101243103A
- Authority
- CN
- China
- Prior art keywords
- hypertension
- blood pressure
- amenorrhoea
- patient
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (12)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP248212/2005 | 2005-08-29 | ||
JP2005248212 | 2005-08-29 | ||
PCT/JP2006/316878 WO2007026651A1 (ja) | 2005-08-29 | 2006-08-28 | 高血圧症治療剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101243103A true CN101243103A (zh) | 2008-08-13 |
CN101243103B CN101243103B (zh) | 2012-04-18 |
Family
ID=37808741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800302630A Expired - Fee Related CN101243103B (zh) | 2005-08-29 | 2006-08-28 | 高血压症治疗剂 |
Country Status (12)
Country | Link |
---|---|
US (1) | US9650408B2 (zh) |
EP (1) | EP1921085B1 (zh) |
JP (1) | JP5094400B2 (zh) |
KR (1) | KR20080037678A (zh) |
CN (1) | CN101243103B (zh) |
AU (1) | AU2006285902B9 (zh) |
BR (1) | BRPI0615346A2 (zh) |
CA (1) | CA2620553C (zh) |
NO (1) | NO20080947L (zh) |
RU (1) | RU2415147C2 (zh) |
TW (1) | TW200740442A (zh) |
WO (1) | WO2007026651A1 (zh) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5447941A (en) * | 1993-12-21 | 1995-09-05 | Eli Lilly And Company | Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes |
US6054446A (en) | 1997-12-24 | 2000-04-25 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
US6548491B2 (en) * | 1997-12-24 | 2003-04-15 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
US6503896B1 (en) | 1997-12-24 | 2003-01-07 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
GB9827121D0 (en) | 1998-12-09 | 1999-02-03 | Orion Corp | Agent for lowering endothelin levels |
AU7896100A (en) * | 1999-10-14 | 2001-04-23 | Endorecherche Inc. | Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance |
GB2374412A (en) | 2001-04-11 | 2002-10-16 | Karobio Ab | Hypertension treatment and assay |
-
2006
- 2006-08-17 TW TW095130284A patent/TW200740442A/zh unknown
- 2006-08-28 EP EP06783107A patent/EP1921085B1/en active Active
- 2006-08-28 BR BRPI0615346-1A patent/BRPI0615346A2/pt not_active IP Right Cessation
- 2006-08-28 CA CA2620553A patent/CA2620553C/en not_active Expired - Fee Related
- 2006-08-28 US US12/064,677 patent/US9650408B2/en active Active
- 2006-08-28 KR KR1020087004118A patent/KR20080037678A/ko not_active Application Discontinuation
- 2006-08-28 CN CN2006800302630A patent/CN101243103B/zh not_active Expired - Fee Related
- 2006-08-28 JP JP2007533228A patent/JP5094400B2/ja not_active Expired - Fee Related
- 2006-08-28 RU RU2008112142/04A patent/RU2415147C2/ru not_active IP Right Cessation
- 2006-08-28 WO PCT/JP2006/316878 patent/WO2007026651A1/ja active Application Filing
- 2006-08-28 AU AU2006285902A patent/AU2006285902B9/en not_active Ceased
-
2008
- 2008-02-26 NO NO20080947A patent/NO20080947L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1921085A4 (en) | 2010-08-25 |
AU2006285902B2 (en) | 2012-06-14 |
KR20080037678A (ko) | 2008-04-30 |
RU2415147C2 (ru) | 2011-03-27 |
BRPI0615346A2 (pt) | 2011-05-17 |
CA2620553C (en) | 2013-05-07 |
JP5094400B2 (ja) | 2012-12-12 |
CA2620553A1 (en) | 2007-03-08 |
EP1921085A1 (en) | 2008-05-14 |
AU2006285902B9 (en) | 2012-07-05 |
JPWO2007026651A1 (ja) | 2009-03-05 |
US20090281071A1 (en) | 2009-11-12 |
TW200740442A (en) | 2007-11-01 |
NO20080947L (no) | 2008-05-16 |
RU2008112142A (ru) | 2009-10-10 |
WO2007026651A1 (ja) | 2007-03-08 |
AU2006285902A1 (en) | 2007-03-08 |
EP1921085B1 (en) | 2012-08-08 |
US9650408B2 (en) | 2017-05-16 |
CN101243103B (zh) | 2012-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2012290987B2 (en) | Left ventricular diastolic function improving agent | |
CN106237334B (zh) | 一种血管紧张素受体拮抗剂和米力农的复合物及其用途 | |
CN102600146B (zh) | 一种盐酸乐卡地平和氯沙坦钾复方制剂及其制备方法 | |
US20160151347A1 (en) | Pharmaceutical compounds | |
CN101243103B (zh) | 高血压症治疗剂 | |
CN106163518A (zh) | 包含血管紧张素‑Ⅱ受体阻断剂和HMG‑CoA还原酶抑制剂的药物复合制剂 | |
Kleber et al. | Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction: results of the German multicenter study of the effects of captopril on cardiopulmonary exercise parameters (ECCE) | |
US8470363B2 (en) | Antihypertensive pharmaceutical composition | |
MXPA04007472A (es) | Terapia de combinacion de un antagonista del receptor de aldoterona y un agente modulador alfa-adrenergico para la prevencion o tratamiento de estados patogenicos. | |
CN101336921A (zh) | 一种瑞舒伐他汀阿折地平组合物 | |
WO2020169041A1 (zh) | 含氨氯地平、氯噻酮和醛固酮受体拮抗剂的药物组合物 | |
WO2020207355A1 (zh) | 含氨氯地平、氯噻酮和阿米洛利的药物组合物 | |
CN110283061A (zh) | 用于降血压的新型化合物及其提取方法 | |
CA2727957A1 (en) | Pharmaceutical composition comprising levamlodipine and indapamide | |
CN102106853A (zh) | 一种治疗高血压的化学药物组合物 | |
Carlsten et al. | Physiological analysis and subsequent surgical treatment of a case of carotid sinus syndrome | |
Frishman et al. | Antiarrhythmic Agents | |
Rahman | In Vitro Kinetic Studies of Combined Amlodipine (5mg) and Atenolol (50mg) Tablet Dosage Form: A Comparative Study with Similar Market Products Available in Bangladesh | |
García et al. | A081: Treatment of the atherogenic lipid profile on menopausal women | |
NZ620451B2 (en) | Left ventricular diastolic function improving agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SRI INTERNATIONAL Free format text: FORMER OWNER: TAIHO PHARMACEUTICAL CO., LTD. Effective date: 20110901 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110901 Address after: California, USA Applicant after: Stanford Res Inst Int. Address before: Tokyo, Japan Applicant before: Taiho Pharmaceutical Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20200828 |
|
CF01 | Termination of patent right due to non-payment of annual fee |